# Andersons, Inc.: overview

ANDE · Nasdaq · CIK 821026 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ande.md) · [Financials](/companies/ande/financials.md) · [Filings](/companies/ande/filings.md) · [Insiders](/companies/ande/insiders.md)

Latest reported revenue: [$555.5m](/filings/0000821026-26-000122.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0000821026-26-000122).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [232](/filings/0000821026-25-000204.md) | [338 d](/filings/0000821026-26-000010.md) | [371](/filings/0000821026-26-000070.md) | [535](/filings/0000821026-26-000122.md) | [296](/filings/0000821026-25-000204.md) | [330 d](/filings/0000821026-26-000010.md) | [379](/filings/0000821026-26-000070.md) | [555](/filings/0000821026-26-000122.md) |
| Gross margin | % | [76.4%](/filings/0000821026-25-000204.md) | [63.1% d](/filings/0000821026-26-000010.md) | [41.2%](/filings/0000821026-26-000070.md) | [29.6%](/filings/0000821026-26-000122.md) | [57.8%](/filings/0000821026-25-000204.md) | [70.3% d](/filings/0000821026-26-000010.md) | [42.4%](/filings/0000821026-26-000070.md) | [40.3%](/filings/0000821026-26-000122.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [11.8%](/filings/0000821026-25-000204.md) | [13.4% d](/filings/0000821026-26-000010.md) | [0.1%](/filings/0000821026-26-000070.md) | [1.5%](/filings/0000821026-26-000122.md) | [6.8%](/filings/0000821026-25-000204.md) | [20.5% d](/filings/0000821026-26-000010.md) | [8.8%](/filings/0000821026-26-000070.md) | [10.2%](/filings/0000821026-26-000122.md) |
| Diluted EPS | $ per share | [0.80](/filings/0000821026-25-000204.md) | not reported | [0.01](/filings/0000821026-26-000070.md) | [0.23](/filings/0000821026-26-000122.md) | [0.59](/filings/0000821026-25-000204.md) | not reported | [0.97](/filings/0000821026-26-000070.md) | [1.65](/filings/0000821026-26-000122.md) |
| Free cash flow | $m | [(40.0) d](/filings/0000821026-25-000204.md) | [213 d](/filings/0000821026-26-000010.md) | [(397)](/filings/0000821026-26-000070.md) | [250 d](/filings/0000821026-26-000122.md) | [167 d](/filings/0000821026-25-000204.md) | [(77.1) d](/filings/0000821026-26-000010.md) | [(445)](/filings/0000821026-26-000070.md) | [412 d](/filings/0000821026-26-000122.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [2,212](/filings/0000821026-24-000071.md) | [3,037](/filings/0000821026-24-000071.md) | [1,632](/filings/0000821026-26-000010.md) | [1,403](/filings/0000821026-26-000010.md) | [1,531](/filings/0000821026-26-000010.md) |
| Gross margin | % | [26.8%](/filings/0000821026-24-000071.md) | [22.5%](/filings/0000821026-25-000050.md) | [45.7%](/filings/0000821026-26-000010.md) | [49.4%](/filings/0000821026-26-000010.md) | [46.6%](/filings/0000821026-26-000010.md) |
| Operating margin | % | not reported | not reported | not reported | not reported | not reported |
| Net margin | % | [4.7%](/filings/0000821026-24-000071.md) | [4.3%](/filings/0000821026-25-000050.md) | [6.2%](/filings/0000821026-26-000010.md) | [8.1%](/filings/0000821026-26-000010.md) | [6.3%](/filings/0000821026-26-000010.md) |
| Diluted EPS | $ per share | [3.07](/filings/0000821026-24-000071.md) | [3.81](/filings/0000821026-25-000050.md) | [2.94](/filings/0000821026-25-000050.md) | [3.32](/filings/0000821026-25-000050.md) | not reported |
| Free cash flow | $m | [(127)](/filings/0000821026-24-000071.md) | [179](/filings/0000821026-25-000050.md) | [796](/filings/0000821026-26-000010.md) | [182](/filings/0000821026-26-000010.md) | [(56.1)](/filings/0000821026-26-000010.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/ande/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $427.7m | 6,252,747 |  | Added +674,654 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $167.4m | 2,447,338 |  | Added +30,615 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $161.1m | 2,355,568 |  | Added +5,195 |
| [Invesco Ltd.](/funds/914208.md) | 2026-06-30 | $112.1m | 1,639,477 |  | Added +416,388 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $99.4m | 1,452,578 |  | Added +109,265 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $99.1m | 1,448,517 |  | Added +9,780 |
| [Rubric Capital Management LP](/funds/1687509.md) | 2026-06-30 | $68.4m | 999,559 |  | Added +143,740 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $68.3m | 997,841 |  | Added +158,114 |
| [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $61.8m | 860,942 |  | Not compared |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $54.6m | 798,215 |  | Not compared |

## Recent filings

[All 2,471 filings](/companies/ande/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-23 | 17:28 ET | [8-K](/filings/0000821026-26-000134.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000821026-26-000134 |
| 2026-08-04 | 16:15 ET | [10-Q](/filings/0000821026-26-000122.md) | Quarterly report, period 2026-06-30 | 0000821026-26-000122 |
| 2026-08-03 | 16:54 ET | [8-K](/filings/0000821026-26-000120.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000821026-26-000120 |
| 2026-06-18 | 12:12 ET | [8-K](/filings/0000821026-26-000104.md) | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0000821026-26-000104 |
| 2026-05-07 | 15:35 ET | [8-K](/filings/0000821026-26-000076.md) | 5.07 Shareholder vote results | 0000821026-26-000076 |
| 2026-05-06 | 10:36 ET | [10-Q](/filings/0000821026-26-000070.md) | Quarterly report, period 2026-03-31 | 0000821026-26-000070 |
| 2026-05-05 | 16:31 ET | [8-K](/filings/0000821026-26-000067.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000821026-26-000067 |
| 2026-03-25 | 09:47 ET | [8-K](/filings/0000821026-26-000048.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000821026-26-000048 |
| 2026-03-11 | 15:03 ET | [DEF 14A](/filings/0001104659-26-026341.md) | Proxy statement, period 2026-03-11 | 0001104659-26-026341 |
| 2026-02-18 | 16:02 ET | [10-K](/filings/0000821026-26-000010.md) | Annual report, period 2025-12-31 | 0000821026-26-000010 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0000821026-26-000010.md), filed Feb 18, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/26c3ce7b-ccf8-4f01-bb1e-efe33327f82c)

## About the filer

- CIK: 821026
- Tickers: ANDE
- Exchange: Nasdaq
- SIC code: 5150 Wholesale-Farm Product Raw Materials
- State of incorporation: OH
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 26, 2026, 10:18 ET. No prices; not investment advice.